New therapeutic approaches to modulate and correct cystic fibrosis transmembrane conductance regulator
T Ong, BW Ramsey - Pediatric Clinics, 2016 - pediatric.theclinics.com
The science of personalized medicine is taking shape in the cystic fibrosis (CF) community
with genotype-directed therapies available for more than half of the CF population …
with genotype-directed therapies available for more than half of the CF population …
[HTML][HTML] New Therapeutic Approaches to Modulate and Correct CFTR
T Ong, BW Ramsey - Pediatric clinics of North America, 2016 - ncbi.nlm.nih.gov
Personalized medicines are now available for over half the cystic fibrosis (CF) population
with genotype-directed therapies that target the underlying defect of CF, abnormal cystic …
with genotype-directed therapies that target the underlying defect of CF, abnormal cystic …
New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator
T Ong, BW Ramsey - Pediatric clinics of North America, 2016 - pubmed.ncbi.nlm.nih.gov
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are clinically
available personalized medicines approved for some individuals with cystic fibrosis (CF) to …
available personalized medicines approved for some individuals with cystic fibrosis (CF) to …
New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.
T Ong, BW Ramsey - Pediatric Clinics of North America, 2016 - europepmc.org
Personalized medicines are now available for over half the cystic fibrosis (CF) population
with genotype-directed therapies that target the underlying defect of CF, abnormal cystic …
with genotype-directed therapies that target the underlying defect of CF, abnormal cystic …
New Therapeutic Approaches to Modulate and Correct Cystic Fibrosis Transmembrane Conductance Regulator.
T Ong, BW Ramsey - Pediatric Clinics of North America, 2016 - europepmc.org
Personalized medicines are now available for over half the cystic fibrosis (CF) population
with genotype-directed therapies that target the underlying defect of CF, abnormal cystic …
with genotype-directed therapies that target the underlying defect of CF, abnormal cystic …